As one top reviewer said, A Simple Cure is an “Intense, Riveting, Medical Thriller.” The novel engages the reader in the search for the cure of malignant melanoma, a cancer that kills one American every hour.
When nature, in her ultimate act of irony, strikes Richard Powell, a cancer specialist, with malignant melanoma, his wife, Terri devotes her life to curing the disease.
While research laboratories are characterized as noble in search of cures, and proprietary drug companies are caricatured as ruthless and materialistic, too often, the distinctions aren’t so clear.
When a drug courier is murdered to obtain an experimental and promising treatment for malignant melanoma, the act unleashes a chain of devastating consequences.
People for Alternative Treatment (PAT), a company created to find cures for rare diseases, has fallen on hard times and becomes a subsidiary of Kendall Pharmaceuticals, a company with very different set of values.
Experimentation with a vaccine against tuberculosis is showing surprising effects in controlling malignant melanoma at PAT and UC Medical Center. Kendall is enthralled with the economic potential of such a treatment, while researchers are leery and have many unanswered questions.
Kendall’s determination to push the vaccine into clinical trial at all costs is in conflict with Terri and her ethical associates.
When clinical trials begin, the vaccine’s effects are miraculous. Soon, however, once again, we see the rule of unintended consequences.